Skip to main content
. 2023 Mar 7;73(730):e332–e339. doi: 10.3399/BJGP.2022.0353

Table 1.

Total observed and predicted incidence rate per 100 000 population in 2020 and 2021 a

Condition 2020 and 2021
Observed Predicted (95% CI) Change (95% CI) Percentage change (95% CI)
COPD 549 892 (779 to 1005) −343 (−456 to −230) −38.4 (−45.4 to −29.5)
Depression 1800 2512 (2194 to 2830) −712 (−1031 to −394) −28.3 (−36.4 to −17.9)
Type 2 diabetes 837 1136 (871 to 1401) −300 (−565 to −34) −26.4 (−40.3 to −3.9)
Hypertension 1663 2231 (1979 to 2483) −568 (−820 to −316) −25.5 (−33 to −16.0)
Anxiety disorders 2503 3333 (2784 to 3882) −830 (−1379 to −281) −24.9 (−35.5 to −10.1)
Asthma 756 1006 (898 to 1114) −250 (−358 to −142) −24.9 (−32.2 to −15.9)
Diabetes mellitus 999 1314 (952 to 1676) −315 (−677 to 47) −24 (−40.4 to 4.9)
Rheumatoid arthritis 148 192 (142 to 243) −45 (−95 to 6) −23.1 (−39.0 to 4.0)
PVD 341 430 (375 to 485) −90 (−145 to −35) −20.8 (−29.8 to −9.2)
Inflammatory bowel disease 147 183 (152 to 214) −36 (−67 to −5) −19.8 (−31.4 to −3.4)
Undetermined type diabetes 123 147 (116 to 178) −24 (−55 to 7) −16.3 (−31.0 to 6.1)
CHD 671 774 (680 to 869) −103 (−198 to −9) −13.3 (−22.8 to −1.3)
Heart failure 756 871 (753 to 990) −116 (−234 to 3) −13.3 (−23.6 to 0.4)
CKD 1462 1678 (1496 to 1861) −217 (−399 to −34) −12.9 (−21.5 to −2.3)
Epilepsy 159 182 (143 to 220) −23 (−61 to 16) −12.4 (−27.9 to 11.4)
Atrial fibrillation 1158 1304 (1145 to 1463) −146 (−305 to 13) −11.2 (−20.8 to 1.1)
Stroke and TIA 592 647 (554 to 740) −55 (−148 to 38) −8.5 (−20.0 to 6.9)
Dementia 1050 1135 (991 to 1279) −85 (−229 to 59) −7.5 (−17.9 to 6.0)
Type 1 diabetes 41 38 (22 to 53) 3 (−12 to 19) 8.6 (−22.8 to 83.3)
a

Conditions are ordered from largest to smallest relative (%) change between observed and predicted rates. CHD = coronary heart disease. CI = confidence interval. CKD = chronic kidney disease. COPD = chronic obstructive pulmonary disease. PVD = peripheral vascular disease. TIA = transient ischaemic attack.